TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

TransEnterix, Inc. (NYSE: TRXC) Investor Investigation Over Possible Wrongdoing Announced

  • Investors who purchased shares of TransEnterix, Inc. (NYSE: TRXC) and currently hold any of those NYSE: TRXC shares have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Transenterix Inc
Security
NYSEMKT: TRXC

Summary

An investigation on behalf of current long-term investors in shares of TransEnterix, Inc. (NYSE: TRXC) was announced over potential breaches of fiduciary duties by certain officers and directors at TransEnterix, Inc.

The investigation by a law firm concerns whether certain TransEnterix, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.

Morrisville, NC based TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. TransEnterix, Inc. reported that its annual Total Revenue rose from $7,11 million in 2017 to $24.1 million in 2018 and that its Net Loss declined from $144.79 million in 2017 to $61.77 million in 2018.

Shares of TransEnterix, Inc. (NYSE: TRXC) declined from $6.87 per share in September 2018 to as low as $2.08 per share on March 25, 2019.

Start Monitoring Your Investments